|
|
Volumn 338, Issue 13, 1998, Pages 908-909
|
|
A novel antidiabetic drug, troglitazone - Reason for hope and concern
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA GLUCOSIDASE INHIBITOR;
GLUCOSE;
INSULIN;
METFORMIN;
SULFONYLUREA DERIVATIVE;
TROGLITAZONE;
CLINICAL TRIAL;
DIABETES CONTROL;
EDITORIAL;
GLUCOSE BLOOD LEVEL;
HUMAN;
HYPOGLYCEMIA;
INSULIN TREATMENT;
LIPID METABOLISM;
LIVER DISEASE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
ADMINISTRATION, ORAL;
CHROMANS;
DIABETES MELLITUS, TYPE 2;
HUMANS;
HYPOGLYCEMIC AGENTS;
LIVER DISEASES;
THIAZOLES;
THIAZOLIDINEDIONES;
|
|
EID: 0032568309
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM199803263381311 Document Type: Editorial |
|
Times cited : (44)
|
|
References (9)
|
